Explanation of metrizamide brain penetration: a review
- PMID: 6988475
- DOI: 10.1097/00004728-198004000-00011
Explanation of metrizamide brain penetration: a review
Abstract
The penetration of intrathecally injected metrizamide into brain and spinal cord substance is a phenomenon that has surprised and puzzled radiologists. No suitable explanation has been offered in the radiologic literature. This article reviews the recent literature on the relationship between the cerebrospinal fluid (CSF) space and the extracellular fluid (ECF) space of the brain. Recent evidence has shown that these spaces are in fact one compartment with no diffusion barrier between them. Thus, penetration of metrizamide into the brain is an expected rather than surprising phenomenon. An explanation is offered as to why metrizamide does not penetrate edematous or infarcted portions of brain on the basis of a pressure gradient between damaged brain ECF and CSF spaces.
Similar articles
-
[Cerebral penetration following metrizamide myelography].J Neuroradiol. 1980;7(1):3-12. J Neuroradiol. 1980. PMID: 7229684 French. No abstract available.
-
Clearance of amine metabolites from the cerebrospinal fluid: the brain as a "sink".Neurology. 1974 Aug;24(8):772-9. doi: 10.1212/wnl.24.8.772. Neurology. 1974. PMID: 4858421 No abstract available.
-
Variations in protein permeability in different regions of the cerebrospinal fluid.Exp Neurol. 1970 Aug;28(2):257-65. doi: 10.1016/0014-4886(70)90234-7. Exp Neurol. 1970. PMID: 5458723 No abstract available.
-
The cerebrospinal fluid and barriers - anatomic and physiologic considerations.Handb Clin Neurol. 2017;146:21-32. doi: 10.1016/B978-0-12-804279-3.00002-2. Handb Clin Neurol. 2017. PMID: 29110772 Review.
-
Measurement of cerebrospinal fluid formation and absorption by ventriculo-cisternal perfusion: what is really measured?Croat Med J. 2014 Aug 28;55(4):317-27. doi: 10.3325/cmj.2014.55.317. Croat Med J. 2014. PMID: 25165046 Free PMC article. Review.
Cited by
-
Iotrol, a new water-soluble non-ionic dimeric contrast medium for intrathecal use.Neuroradiology. 1985;27(4):337-41. doi: 10.1007/BF00339568. Neuroradiology. 1985. PMID: 3900800 Clinical Trial.
-
Subacute reactions to intrathecal amipaque (metrizamide), conray and dimer X: a structural and ultrastructural study.Neuroradiology. 1981 Jan;20(5):229-33. doi: 10.1007/BF00342089. Neuroradiology. 1981. PMID: 6894018
-
Syringomyelia in association with tumours of the posterior fossa. Pathophysiological considerations, based on observations on three related cases.Acta Neurochir (Wien). 1995;137(1-2):38-43. doi: 10.1007/BF02188778. Acta Neurochir (Wien). 1995. PMID: 8748866
-
Multiple subcortical haemorrhages following lumbar metrizamide myelography.J Neurol. 1987 Apr;234(3):177-9. doi: 10.1007/BF00314139. J Neurol. 1987. PMID: 2953869
-
Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis.Neurosurg Rev. 2010 Jul;33(3):271-84; discussion 284-5. doi: 10.1007/s10143-010-0266-5. Epub 2010 Jun 8. Neurosurg Rev. 2010. PMID: 20532585 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources